Free Trial

Varex Imaging (NASDAQ:VREX) Releases Q4 2025 Earnings Guidance

Varex Imaging logo with Medical background

Key Points

  • Varex Imaging updated its Q4 2025 earnings guidance, projecting earnings per share between $0.100 and $0.300, exceeding the consensus estimate of $0.098.
  • The company provided a revenue forecast of $210 million to $230 million, surpassing the consensus estimate of $197.9 million.
  • Varex Imaging's stock increased by 10.9%, reaching $7.81, with an unusually high trading volume of over 1 million shares.
  • Need Better Tools to Track VAREX IMAGING? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Varex Imaging (NASDAQ:VREX - Get Free Report) updated its fourth quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.100-0.300 for the period, compared to the consensus earnings per share estimate of 0.098. The company issued revenue guidance of $210.0 million-$230.0 million, compared to the consensus revenue estimate of $197.9 million.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on VREX shares. B. Riley upgraded shares of Varex Imaging to a "strong-buy" rating in a report on Monday, May 12th. Wall Street Zen raised Varex Imaging from a "buy" rating to a "strong-buy" rating in a research report on Saturday, July 5th.

View Our Latest Stock Analysis on Varex Imaging

Varex Imaging Stock Up 10.9%

Varex Imaging stock traded up $0.77 during mid-day trading on Thursday, hitting $7.81. The company had a trading volume of 1,097,865 shares, compared to its average volume of 461,231. The stock's 50 day moving average price is $8.00 and its two-hundred day moving average price is $9.79. The company has a market capitalization of $321.77 million, a PE ratio of -7.58 and a beta of 0.68. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $16.93. The company has a current ratio of 4.05, a quick ratio of 2.36 and a debt-to-equity ratio of 1.00.

Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.14. Varex Imaging had a positive return on equity of 4.91% and a negative net margin of 5.08%. As a group, sell-side analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Varex Imaging

An institutional investor recently raised its position in Varex Imaging stock. Jane Street Group LLC raised its holdings in shares of Varex Imaging (NASDAQ:VREX - Free Report) by 17.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 159,362 shares of the company's stock after buying an additional 24,160 shares during the period. Jane Street Group LLC owned about 0.39% of Varex Imaging worth $1,849,000 at the end of the most recent reporting period.

About Varex Imaging

(Get Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Featured Articles

Earnings History and Estimates for Varex Imaging (NASDAQ:VREX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in VAREX IMAGING Right Now?

Before you consider VAREX IMAGING, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VAREX IMAGING wasn't on the list.

While VAREX IMAGING currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines